AI and next-generation genomic sequencing are used to reconstruct how cancer evolves from normal cells to malignant disease. Building on computational models for breast, prostate and bladder cancer and AI-driven prognostic tools for breast and lung cancer, this research identifies molecular events behind progression and outcomes. Collaborators can help advance earlier detection, prognosis and precision treatment.

Photobiomodulation research examines how low-dose light triggers non-thermal processes that activate growth factors and support tissue repair. By linking molecular mechanisms with dosimetry that accounts for light absorption and scattering, this work aims to make red-light therapy more reproducible. Collaboration can advance precise dosing, clinical translation and treatments for pain, inflammation and wound healing.